O. Militano | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where O. Militano is active.

Explore More

Publication

Featured researches published by O. Militano.

Biology of Blood and Marrow Transplantation | 2007

185: Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot study

Darrell J. Yamashiro; A. Lee; Monica Bhatia; J. Glade-Bender; E. Qualter; O. Militano; Lauren Harrison; V. Davenport; K. Cheung; M.B. Bradley; James Garvin; G. Del Toro; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2007

76: Reduced intenity allogeneic stem cell transplantion followed by targeted consolidation immunotherapy with gemtuzumab ozogamicin in children and adolescents with CD33+ acute myeloid leukemia

E. Roman; E. Cooney; O. Militano; K. Wolownik; R. Hawkes; S. Foley; Prakash Satwani; J. Guerra; Monica Bhatia; B. Bradley; Diane George; James Garvin; L.A. Baxter-Lowe; Joseph E. Schwartz; Y.-K. Cheung; C. van de Ven; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2006

3: Reduced Intensity (RI) aLlogeneic Cord Blood Hematopoietic Cell Transplantation (Allo-CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases

Prakash Satwani; G. Del Toro; M.B. Bradley; Erin Morris; C. van de Ven; Y.-K. Cheung; Darrell J. Yamashiro; James Garvin; Monica Bhatia; E. Roman; Joseph E. Schwartz; O. Militano; E. Cooney; K. Wolownik; R. Hawks; S. Foley; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2006

A pilot study of myeloablative (MA) autologous stem cell (autoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and adolescents with relapsed hodgkin’s disease (HD) and non-hodgkin’s lymphoma (NHL)

M.B. Bradley; E. Cooney; Diane George; James Garvin; G. Del Toro; Monica Bhatia; E. Roman; Prakash Satwani; O. Militano; Y.-K. Cheung; K. Kelly; C. van de Ven; Joseph E. Schwartz; R. Gewanter; Paul L. Martin; Joanne Kurtzberg; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2011

Iv Busulfan Administered Q12 Vs Q6 Hrs During Conditioning of Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Has Comparable Pharmacokinetics and Significant Reduction in Nursing/Pharmacist Costs

J.B. LeGall; Michael C. Milone; Ian M. Waxman; Leslie M. Shaw; Lauren Harrison; D. Duffy; O. Militano; Monica Bhatia; Prakash Satwani; Diane George; James Garvin; M.B. Bradley; C. van de Ven; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2007

315: Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients

O. Militano; D. Hedgpeth; Leslie M. Shaw; Michal Figurski; P. Satwani; J. Ayello; E. Roman; B. Bradley; D. George; J. Garvn; M. Bhatia; K. Wolownick; S. Foley; R. Hawkes; M.S. Cairo

Biology of Blood and Marrow Transplantation | 2009

Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days In Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Pharmacokinetically Similar to Q6 Hour Dosing in the Pediatric Population

Ian M. Waxman; Michael C. Milone; Monica Bhatia; Leslie M. Shaw; Virginia Moore; B. Tallamy; O. Militano; James Garvin; Diane George; M.B. Bradley; Prakash Satwani; Joseph E. Schwartz; K. Wolownik; S. Foley; R. Hawks; L.A. Baxter-Lowe; C. van de Ven; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2008

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

Ian M. Waxman; Monica Bhatia; Michael C. Milone; Leslie M. Shaw; L. Baldinger; O. Militano; James Garvin; Diane George; M.B. Bradley; Prakash Satwani; Joseph E. Schwartz; K. Wolownik; S. Foley; R. Hawks; Zhezhen Jin; L.A. Baxter-Lowe; C. van de Ven; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2007

163: Systemic viral and fungal infections are not significantly decreased following reduced intensity allogeneic stem cell transplantation (RIAlloSCT) in children and adolescent recipients with malignant and nonmalignant diseases

J. Guerra; Prakash Satwani; L. Baldinger; C. van de Van; E. Roman; James Garvin; M.B. Bradley; Monica Bhatia; Diane George; Joseph E. Schwartz; R. Hawkes; K. Wolownik; S. Foley; Erin Morris; O. Militano; Mitchell S. Cairo

Biology of Blood and Marrow Transplantation | 2007

212: Adenovirus (ADV) infections following allogeneic stem cell transplant (alloSCT) in children and adolescent recepients

J. Oesterheld; Diane George; B. Bradley; G. Del Toro; James Garvin; Monica Bhatia; Prakash Satwani; E. Roman; E. Cooney; O. Militano; R. Hawkes; K. Wowolnik; S. Foley; Joseph E. Schwartz; Mitchell S. Cairo

Explore More